Elevated Lp(a) levels are a significant cardiovascular risk factor, particularly for young individuals and for subjects with concomitant high LDL cholesterol. Increased Lp(a) is believed to be linked to an enhanced production of the lipoprotein, controlled by genetic factors; it can be reduced by agents such as nicotinic acid, lowering free fatty acid inflow to the liver.
L-carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a) / C. R. Sirtori, L. Calabresi, S. Ferrara, F. Pazzucconi, A. Bondioli, D. Baldassarre, A. Birreci, A. Koverech. - In: NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. - ISSN 0939-4753. - 10:5(2000 Oct), pp. 247-251.
L-carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a)
C. R. Sirtori;L. Calabresi;F. Pazzucconi;D. Baldassarre;
2000
Abstract
Elevated Lp(a) levels are a significant cardiovascular risk factor, particularly for young individuals and for subjects with concomitant high LDL cholesterol. Increased Lp(a) is believed to be linked to an enhanced production of the lipoprotein, controlled by genetic factors; it can be reduced by agents such as nicotinic acid, lowering free fatty acid inflow to the liver.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
